We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.49% | 16.50 | 16.00 | 17.00 | 16.75 | 16.50 | 16.75 | 169,683 | 14:04:40 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.81 | 15.05M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/9/2017 16:02 | Las Vegas expo not LA expo. Listened again to the interview elrico, next few weeks and months should be exciting | imnotlong | |
01/9/2017 15:56 | Parob - we are singing from the same hymesheet. It was the point I was making yesterday. SACCO signatories were shut down for the jollies for 4 weeks and now back, hence I why expect a pickup in the pace of RNS's over the next 4 months. Of course by October we will almost certainly have new expectations post the LAS VEGAS Expo. SACCO are intent of cracking the huge US markets. It's also worth noting, the deal with SACCO increases the already high margins by 33%. Of course we don't know the margins. SOH did say they can mass produce the raw ingredients very cheaply. It's clear SACCO are eager to impress, hence why they are paying for the joint venture and funding new product developments. Can anyone name another company that is only just entering the commercial sphere, has companie falling over themselves to join the venture, pay for research and development, thus further derisking and shaving what small capex there is off. I am struggling to find a comparison. OPTI will be throwing off cash within the next 12 months and TLTers can wag a finger and say we told you so. | elrico | |
01/9/2017 14:40 | In Elrico's interview SOH said they'd pretty much agreed the global Sacco deal 4 weeks before the announcement but had to wait for the signatory to return from holidays.How many other deals were agreed in principal before the summer holiday period...Bid continues to rise and now 74.3p to buy. Could see another tick up by the EOP. | parob | |
01/9/2017 14:19 | Hey Ray mate, you bear all the signs of a TW BASHER, just like the OPNow you have not heard of TCM, you do surprise me, old bean . Let me tell you , it's one for TRADERS and you could have bought it for little over 100 just a few wee days ago , now as I speak it is 170 odd and you could have made a killing , as if you did not know Now away with you and your scummy type, | lukead | |
01/9/2017 13:48 | Hey up Ray, what you doing here ? Far too safe for you / no need for nail biting. Been invested here since 34p and expect their patented IP to take us over a quid early next year. One thing for sure -- there'll be no plug + abandoned RNS - lol | westmoreland lad | |
01/9/2017 13:27 | Tcm? Not a clue what you are talking about. But take care with this one, there's not phase 1/2/3 testing here...the same at meldex! | rayrac | |
01/9/2017 12:37 | Also with Barclays. I have been spending more time with my 'phone! | fredd | |
01/9/2017 12:27 | With sharecentre always been reliable online. History of all ones trades etc. Works for me in nms. They will deal above that but you leave it to their dealers to work it or call them to do it live. | xippy | |
01/9/2017 11:59 | Also with barclays, total shambles. | belgrano2 | |
01/9/2017 11:53 | ...Only just seen it westy. Reply sent. | someuwin | |
01/9/2017 11:44 | someuwin -- sent you a message via ADVFN yesterday. Did you receive it ? | westmoreland lad | |
01/9/2017 11:23 | Tried almost all online brokers over the years. Never found one yet that didn't have problems some of the time. Best thing is to have multiple (ISA) accounts with differnt brokers then you have others to fall back on if one is offline. Also useful as sometimes one broker can supply more stock than another one. | someuwin | |
01/9/2017 11:12 | Been with TD for 17 years never had any problems ...although I can't compare as never used anyone else. | onedayrodders | |
01/9/2017 10:37 | TDD works well for me. I have one trading account and 4 ISA accounts for family members - all with TDD. Easy and inexpensive to Bed and Isa with a single phone call | kipper1960 | |
01/9/2017 10:19 | TDD also works reasonably well for me. Not overly intuitive, but functions well enough. One thing - it doesn't like you changing devices to access it (i.e. ones it hasn't previously recognised), which is obviously a security measure, but not the end of the world. Best wishes - Mike | spike_1 | |
01/9/2017 10:07 | TDDirect investing, give them a look? Works for my needs, but their efficient.. So far, not let me down... 👍 | joyjoy13 | |
01/9/2017 09:58 | Don't get me started on the new Barclays smart investor. Can't see my share isa ... Can't contact them. Racked up 7 hrs so far this week in a phone queue. Been told they have a 40 day back long on complaints. Can anyone recommend a different broker to switch to where you can see history, broker views etc | suzypink | |
01/9/2017 09:47 | Before I go out... "A rising average is support. A falling average is resistance." To expand - a rising average is not resistance should the price fall below. Conversely, a falling average is not support. This behaviour differs from a trendline which flips from support to resistance and vice versa. M | marnewton | |
01/9/2017 09:45 | And SACCO back from the annual shutdown. | elrico | |
01/9/2017 09:38 | Thanks shrewmole... | bobdown2 | |
01/9/2017 09:37 | Also found this interesting in the results:In the last six months, we have extended our work into OTHER microbial general associated with health benefits directly, or through the production of bioactives, like short chain fatty acids (SCFA's) | parob | |
01/9/2017 09:36 | It's starting! | someuwin | |
01/9/2017 09:35 | Bob From all the updates and interviews I suspect we are in for a busy run up to year end. The last sentence of the interims was a give away, was it 'busy and rewarding rest of 2017' or something to that effect. S | shrewdmole | |
01/9/2017 09:31 | Don't allow the facts to get in the way of the GoFigure drama. Soft launch end of July to Christmas 2016. Launch was officially New Year. Wholefood deal signed August 2016 for a handful of stores. Rivital and Icelandic outlets were not on stream until late Jan/Feb 2017. OPTI own 64% of THWLC not 100%. What is Michalemouse expecting to show in the interims for a period that end April? He once again demonstrates more reasons why he should use a fund manager rather use his own cognitive and perhaps he would avoid disasters like, AVN, INTQ, TRAKM8, TDIG, SLI to name just a few. He of course avoid the elephant in the room, the awkward fact GoFigure is the reason TATA have signed a commercial deal for India and Asian markets, which will soon be on stream. GoFigure has been a wonderful marketing tool for SlimBiome. Christina has took over THWLC because she has a proven record in retail and building a multi million $ sales whereas Max is best suited to running and running and running as well as his nutritional advice, he has not record to compare to Christina. Had TRAK8 installed its so dynamic telematic into a small fleet of vehicles and a few months later AA with a fleet x30/40 time larger signed up I am sure Michalemouse would say that was a fantastic marketing tool. Oh wait....Just like OPTI, TRAK8 issued a contract RNS, guess what? No revenue guidance. Guess what? No stupid comment about this anomaly we get from him but he is quick off the mark to trash OPTI will conspiracy theories when OPTI announce the same. Double standards and hypocrisy. | elrico | |
01/9/2017 09:29 | Lots of Opti in my Barclays acc. Not that I can get to any of it at the moment. It will be nice to see continuos progress to keep the pot boiling.. | bobdown2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions